Effect of disease duration in a randomized Phase III trial of rintatolimod, an immune modulator for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

by David R Strayer, Diane Young, William M Mitchell
Published 2020-01-01

Qualitative and quantitative detection of Chlamydophila pneumoniae DNA in cerebrospinal fluid from multiple sclerosis patients and controls.

by Yi-Wei Tang, Subramaniam Sriram, Haijing Li, Song-yi Yao, Shufang Meng, William M Mitchell, Charles W Stratton
Published 2009-01-01

A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome.

by David R Strayer, William A Carter, Bruce C Stouch, Staci R Stevens, Lucinda Bateman, Paul J Cimoch, Charles W Lapp, Daniel L Peterson, Chronic Fatigue Syndrome AMP-516 Study Group, William M Mitchell
Published 2012-01-01